Silence Therapeutics (SLN) Stock Price & Financial Analysis
Silence Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Silence Therapeutics
What is the current stock price for SLN?
As of the latest trading session, SLN stock trades at $5.77. The 52-week range is $3.82–$8.40, with a day range of $5.74–$6.27.
What is the P/E ratio for SLN?
The P/E ratio (Price-to-Earnings) for SLN is shown in the Key Statistics section. This valuation metric helps compare Silence Therapeutics plc to industry peers.
Does SLN pay dividends?
Silence Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for SLN?
Based on 1 analyst, the consensus for SLN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of SLN?
Silence Therapeutics's market capitalization is $272.5M, classifying it as a micro-cap company. Silence Therapeutics operates in the Healthcare sector within the Biotechnology industry.